This order directs federal agencies, including the Departments of Education and Health and Human Services, to review and revise guidelines related to the diagnosis and treatment of neurodevelopmental and behavioral conditions in children. The primary focus is to ensure that diagnoses and subsequent treatments, particularly pharmacological interventions, are evidence-based and not influenced by non-medical factors.